Home › Burkitt Lymphoma › West Virginia

Pag-aaral pangklinika para sa Burkitt Lymphoma sa West Virginia

3 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa West Virginia.

Opisyal na teksto ng pag-aaral (English)

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

West Virginia University Healthcare, Morgantown

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

West Virginia University Charleston Division, Charleston
West Virginia University Healthcare, Morgantown

Nagre-recruitPhase 2

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

West Virginia University Charleston Division, Charleston

Nagre-recruitPhase 3

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.